You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1151 to 1175 of about 5947
Next 25
04/27/2019
National Walk To End Brain Tumors
04/20/2019
Cancer and the dopamine D2 receptor: a pharmacological perspective.
04/18/2019
Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas
04/15/2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma - pooled analysis.
Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: a case report
04/11/2019
`I Love What I Do` - Internationally Renowned Brain Surgeon Dr. Linda Liau
04/09/2019
Case Report in the Journal of Neurosurgery Highlights Potential of ONC201 in H3 K27M-mutant DIPG
Optune Open Houses
04/03/2019
Phase 2 study of Val-083 with radiation therapy for newly diagnosed
New Glioblastoma Vaccine Shows Promising Results in Phase 1b Clinical Trial
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
03/31/2019
New glioblastoma vaccine shows promising results in phase Ib clinical trial
Could £400-per-year drug cocktail be the key to beating one of the most-deadly cancers?
03/28/2019
New Strategies Take On the Worst Cancer—Glioblastoma
03/20/2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
03/15/2019
First-Of-Its-Kind Treatment Beats Back Notorious Brain Tumor
03/14/2019
03/13/2019
Newly Diagnosed Glioblastoma: A Review on Clinical Management
03/12/2019
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
Northwell neurosurgeons remove “glowing” brain tumor using breakthrough technology in Long Island first
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
03/10/2019
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
03/09/2019
Update on Medicare CAC meeting